Prevalence of Smoking After Lung Transplantation

NCT07050004 | Completed

• 1 other identifier: 2023-A00918-37
• Study Type: observational
• Target: 1,099
• Locations: 1 country
• Sites: 1

Brief Summary

Smoking is one of the main risk factors for chronic obstructive pulmonary disease (COPD), the primary indication for lung transplantation (LT) in France. Resumption of smoking after transplantation is associated with an increased risk of graft dysfunction, neoplasia and reduced survival. The prevalence of resumption of smoking after transplantation is based on few data available in the literature and is estimated at between 0 and 15%. The aim of this study is to determine the prevalence of smoking in transplantation. These results will enable healthcare professionalś to carry out information, education, prevention and support actions to help patients stop smoking throughout the transplantation process.

Conditions

Tobacco Smoking; Lung Transplantation

Outcome Measures

Primary Outcomes (1)

• Assessing the prevalence of active smoking in post-lung transplantation sing a questionnaire

  Proportion of transplant patients with active smoking

  one year post transplantation

Interventions

SMOKING BEHAVIORAL

Patients who agree to take part in the study will complete a questionnaire covering the pre- and post-transplant aspects of smoking on their lifestyle

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who have benefited from a lung or cardiopulmonary transplantation

You may qualify if:

• Patient who has undergone a lung transplant (single, double or heart-lung) and is being followed up in a transplant centre in France;
• Age ≥ 18 years;
• French-speaking patient;
• Patient able to give his non-opposition.

You may not qualify if:

• Patient under guardianship or curatorship;
• Patient deprived of liberty ;
• Patient under court protection;
• Patients who object to the use of their data for this research.

Sponsors & Collaborators

• Fondation Hôpital Saint-Joseph: lead

Study Sites (1)

Hopital Marie Lannelongue

Le Plessis-Robinson, 92350, France

Location

MeSH Terms

Conditions

Tobacco Smoking

Interventions

Smoking Devices

Condition Hierarchy (Ancestors)

Smoking; Behavior; Tobacco Use

Intervention Hierarchy (Ancestors)

Manufactured Materials; Technology, Industry, and Agriculture

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 18, 2025
• First Posted: July 3, 2025
• Study Start: May 1, 2023
• Primary Completion: July 11, 2024
• Study Completion: December 11, 2024
• Last Updated: July 3, 2025

Record last verified: 2025-06

Locations

FR (1)